If major depressive disorder symptoms fail to respond to standard treatment (such as selective serotonin reuptake inhibitors [SSRIs]), a second agent is sometimes added. A recent systematic review found some evidence of the clinical utility of adjunctive lithium, but the majority of supportive evidence is dated. The same review found no evidence to support the use of lithium for monotherapy.